The 5-year Tysabri global observational program in safety (TYGRIS) study confirms the long-term safety profile of natalizumab treatment in multiple sclerosis
Title:
The 5-year Tysabri global observational program in safety (TYGRIS) study confirms the long-term safety profile of natalizumab treatment in multiple sclerosis
Author:
Foley, John Carrillo-Infante, Cynthia Smith, Jonathan Evans, Karleyton Ho, Pei-Ran Lee, Lily Kasliwal, Rachna Stangel, Martin Vermersch, Patrick Hutchinson, Michael Marinelli, Fabiana Smirnakis, Karen